San Diego, California--(Newsfile Corp. - March 15, 2024) - Hempacco Co, Inc. (NASDAQ: HPCO) ("Hempacco"), a hemp smokables company Disrupting Tobacco's™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, proudly announces a significant partnership with WARPD Labs through a $250K purchase order. This collaboration will see Hempacco producing a cutting-edge, private-label line of vapes, hemp pre-rolls, and gummies using a proprietary blend of hemp-derived cannabinoids exclusively for WARPD Labs.
The much-anticipated product line is set to be unveiled at the upcoming Alternative Products Expo in the Mana Wynwood Convention Center in Miami, where WARPD Labs will showcase these groundbreaking offerings at Booth #2122 on March 14 - 16, 2024.
WARPD Labs, celebrated for its visionary approach in the sphere of cannabinoid exploration and product creation, stands as a trailblazer in the cannabis domain. Their dedication to excellence, authenticity, and pioneering spirit harmonizes perfectly with Hempacco's ambition to transform consumer products with hemp-derived solutions. The forthcoming product range, born from the collaboration between Hempacco and WARPD Labs, showcases bespoke packaging and seven distinctive interdimensional formulations conceived by the creative minds at WARPD Labs. These offerings are genuinely unparalleled and groundbreaking.
Kirk Fuqua, CEO of the American division of WARPD Labs, conveyed his excitement about the groundbreaking partnership with Hempacco, emphasizing its pivotal role in establishing WARPD Labs as the first company to introduce interdimensional cannabis infusions to the U.S. market, a move set to redefine the industry with unparalleled innovation and product excellence.
Sandro Piancone, CEO at Hempacco, shared his excitement about the collaboration, "Our partnership with WARPD Labs represents a significant leap forward in our quest to innovate within the hemp industry. The Alternative Products Expo in Miami will be a landmark showcase of our joint efforts. Together, we are setting a new standard for what consumers can expect from hemp-based products."
HPCO WARPD Labs Collaboration
This collaboration marks a pivotal moment for Hempacco, reinforcing its role as a leader in the hemp industry and its commitment to innovation and quality. The unveiling at the Alternative Products Expo is just the beginning of what promises to be a fruitful partnership between Hempacco and WARPD Labs, poised to bring exciting new products to the forefront of the wellness and recreational cannabis sectors.
About WARPD Labs
Warpd Labs is a pioneering international interdimensional cannabis company thrilled to announce its strategic partnership with Hempacco, a leader in the cannabis production industry, to enhance its US operations. This collaboration marks a significant milestone for WARPD Labs as it expands its innovative product offerings in the United States, leveraging Hempacco's extensive experience and meticulous attention to detail.
To learn more, visit https://warpdlabs.com/
About Hempacco
Hempacco Co., Inc.'s goal is Disrupting Tobacco's™ nearly $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables and rolling paper. Hempacco owns The Real Stuff™ functional hemp cigarette and rolling paper brand. Hempacco is a majority-owned subsidiary of Green Globe International Inc. (OTC Pink: GGII), a fast-moving consumer goods incubating company.
Hempacco's operating segments include:
Learn more at www.hempacco.com
Learn more at www.ggiigroup.com
Order products at www.realstuffsmokables.com
For investor inquiries, please contact:
Sandro Piancone, CEO
Investor Relations: This email address is being protected from spambots. You need JavaScript enabled to view it.
619-779-0715
Safe Harbor Statement
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: (i) potential failure to meet projected development and related targets; (ii) changes in applicable laws or regulations that may impact our products and business; (iii) the effect of the COVID-19 pandemic on the Company and its current or intended markets; and (iv) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the "S.E.C.") by the Company. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
Last Trade: | US$0.02 |
Daily Volume: | 0 |
Market Cap: | US$101K |
April 30, 2024 March 26, 2024 March 21, 2024 December 06, 2023 |
Else Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORELeveraging its vertically-integrated approach from mine to material manufacturing, Graphite One intends to produce high-grade anode material for the lithium-ion electric vehicle battery market and energy storage systems...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS